Feng Du

Statistics

Publications

Citations

H-Index

Active since

2009

Affiliations

Chinese Academy of Medical Sciences & Peking Union Medical College(Current)

Peking University

Peking University Cancer Hospital

National Clinical Research Center for Digestive Diseases

Capital Medical University

Feng Du is an author at Chinese Academy of Medical Sciences & Peking Union Medical College specializing in medicine, oncology, and malignant neoplasms.

ORCID

Publications per year

2009–2024

Publications

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Yongkun Sun, Wei Niu, Feng Du et al. · Journal of Hematology & Oncology · 2016 · 431 citations · Full text

Medicine, Oncology, Pharmacology +15

Safety and Efficacy of Anlotinib, a Multikinase Angiogenesis Inhibitor, in Patients with Refractory Metastatic Soft-Tissue Sarcoma

Yihebali Chi, Zhiwei Fang, Xiaonan Hong et al. · Clinical Cancer Research · 2018 · 332 citations

Medicine, Oncology, Pharmacology +17

miR-143 and miR-145 inhibit gastric cancer cell migration and metastasis by suppressing MYO6

Chao Lei, Feng Du, Lina Sun et al. · Cell Death and Disease · 2017 · 173 citations · Full text

Medicine, Molecular Biology, Oncology +17

Anlotinib for the Treatment of Patients with Locally Advanced or Metastatic Medullary Thyroid Cancer

Yongkun Sun, Feng Du, Ming Gao et al. · Thyroid · 2018 · 113 citations

Medicine, Oncology, Pharmacology +13

DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways

Feng Du, Lina Sun, Yi Chu et al. · Cancer Communications · 2018 · 107 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 35